Skip to main content
. 2020 Oct 3;25(11):e1753–e1762. doi: 10.1634/theoncologist.2020-0055

Figure 2.

Figure 2

Time‐to‐event results by baseline renal functional status and by baseline hepatic functional status. (A): Real‐world time to treatment discontinuation (rwTTD) of first‐line immune checkpoint inhibitor (ICI) treatment and (B) overall survival (OS) by baseline renal functional status. (C): Time to ICI treatment discontinuation (rwTTD) and (D) OS by baseline hepatic functional status.